Sánchez-Torres Ana M, Amoretti Silvia, Enguita-Germán Mónica, Mezquida Gisela, Moreno-Izco Lucía, Panadero-Gómez Rocío, Rementería Lide, Toll Alba, Rodriguez-Jimenez Roberto, Roldán Alexandra, Pomarol-Clotet Edith, Ibáñez Ángela, Usall Judith, Contreras Fernando, Vieta Eduard, López-Ilundain Jose M, Merchán-Naranjo Jessica, González-Pinto Ana, Berrocoso Esther, Bernardo Miguel, Cuesta Manuel J
Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain; Navarra Institute of Health Research (IdiSNA), Pamplona, Spain.
Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, University of Barcelona, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Spain; Bipolar and Depressive Disorders Unit, Hospital Clinic of Barcelona, Institute of Neurosciences, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR); Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
Eur Neuropsychopharmacol. 2023 Feb;67:53-65. doi: 10.1016/j.euroneuro.2022.11.011. Epub 2022 Dec 8.
Schizophrenia is frequently characterized by the presence of multiple relapses. Cognitive impairments are core features of schizophrenia. Cognitive reserve (CR) is the ability of the brain to compensate for damage caused by pathologies such as psychotic illness. As cognition is related to CR, the study of the relationship between relapse, cognition and CR may broaden our understanding of the course of the disease. We aimed to determine whether relapse was associated with cognitive impairment, controlling for the effects of CR. Ninety-nine patients with a remitted first episode of schizophrenia or schizophreniform disorder were administered a set of neuropsychological tests to assess premorbid IQ, attention, processing speed, working memory, verbal and visual memory, executive functions and social cognition. They were followed up for 3 years (n=53) or until they relapsed (n=46). Personal and familial CR was estimated from a principal component analysis of the premorbid information gathered. Linear mixed-effects models were applied to analyse the effect of time and relapse on cognitive function, with CR as covariate. Patients who relapsed and had higher personal CR showed less deterioration in attention, whereas those with higher CR (personal and familial CR) who did not relapse showed better performance in processing speed and visual memory. Taken together, CR seems to ameliorate the negative effects of relapse on attention performance and shows a positive effect on processing speed and visual memory in those patients who did not relapse. Our results add evidence for the protective effect of CR over the course of the illness.
精神分裂症的常见特征是多次复发。认知障碍是精神分裂症的核心特征。认知储备(CR)是大脑对诸如精神病性疾病等病理所造成损害进行补偿的能力。由于认知与认知储备相关,对复发、认知和认知储备之间关系的研究可能会拓宽我们对该疾病病程的理解。我们旨在确定复发是否与认知障碍相关,并控制认知储备的影响。对99例首次发作的精神分裂症或分裂样障碍已缓解的患者进行了一系列神经心理学测试,以评估病前智商、注意力、处理速度、工作记忆、言语和视觉记忆、执行功能及社会认知。对他们进行了3年的随访(n = 53),或直至其复发(n = 46)。根据收集到的病前信息进行主成分分析来估计个人和家族认知储备。应用线性混合效应模型分析时间和复发对认知功能的影响,并将认知储备作为协变量。复发且个人认知储备较高的患者在注意力方面的衰退较小,而未复发且认知储备较高(个人和家族认知储备)的患者在处理速度和视觉记忆方面表现更好。总体而言,认知储备似乎可减轻复发对注意力表现的负面影响,并对未复发患者的处理速度和视觉记忆产生积极影响。我们的结果为认知储备在疾病病程中的保护作用增添了证据。